Top Stories
The transaction is expected to be finalized in early 2020.
/ read more /
The company will invest $24 million into its Inchinnan, Scotland, site to expand global bioproduction capabilities with additional large-volume liquid manufacturing capacity for cell-culture media.
/ read more /
|
|
|
SubscribeSubscribers can enjoy each full issue of BioPharm International in print, or via BioPharm apps.
subscription offers
|
|
|
|
ADVERTISEMENT
Biopharma N-Glycan Analysis Resource Center
An online resource with useful tools and practical information to find out more about Biopharma N-Glycan Analysis. The site provides useful webcasts, videos, application notes, posters, and more.
Learn More » 
|
|
|
|
Industry News
Scientists from the University of Texas Medical Branch in Galveston and Profectus BioSciences of New York have developed the candidate quadrivalent VesiculoVax vaccine, an investigational vaccine that protected monkeys against four types of hemorrhagic fever viruses endemic to overlapping regions in Africa.
/ read more /
The winners were announced during day one of CPhI Worldwide.
/ read more /
More Industry News
|
|
|
|
advertisement
|
advertisement
|
|
|
|
|
|
ADVERTISEMENT
PepTalk: The Protein Science Week | January 20-24, San Diego
More than 1,300 researchers from around the world convene at PepTalk each year to hear inspiring presentations from industry experts and for valuable networking opportunities. Scheduled events include 20 topic-focused conferences, short courses, training seminars, interactive roundtables, dedicated exhibit and poster viewing hours.
View the speaker lineup and programs being offered, visit CHI-PepTalk.com.
Learn More » 
|
|
|
|
Biopharma News
The new addition will also launch a single-use bioreactor for the 93,000-ft2 facility.
/ read more /
Through the agreement, Samsung will provide flexible business terms while offering full regulatory support and improved batch release from small to large scale.
/ read more /
More Biopharma News
|
|
|
|
Supplier News
Schott will combine its adaptiQ platform with West’s Ready Pack system.
/ read more /
|
|
|
The technology is set to heighten the company’s GPEx expression platform through the utilization of a glutamine synthase knock-out Chinese hamster ovary cell line.
/ read more /
More Supplier News
|
|
|
ADVERTISEMENT
Featured Resources from BioPharm International
View our online resource center, sponsored by GE Healthcare, to explore a case study and articles on gaining and retaining skilled labor, modular bioprocessing, the good and bad of biosilimiars, and more.
Access all resources
Learn More » 
|
|
|
|
Regulatory News
In a statement, Janet Woodcock MD, director of FDA’s Center for Drug Evaluation and Research, highlighted the agency’s efforts to enhance the efficiency of postmarket drug safety surveillance.
/ read more /
|
|
|
|
|
|
DRUG DEVELOPMENT
A look at the skill sets and training needed to tackle the increasing levels of automation in bioprocessing facilities.
/ read more /
|
|
|
|
Events
December 4-5, 2019
December 4-6, 2019
December 4–5, 2019
more events
|
|
|
eBook
|
The editors examine the technology, practices, and regulatory approval questions facing companies employing single-use technologies for commercial manufacturing.
|
|
|
|
| |
